Compare BCS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCS | ABT |
|---|---|---|
| Founded | 1690 | 1888 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.0B | 152.9B |
| IPO Year | 2006 | 2006 |
| Metric | BCS | ABT |
|---|---|---|
| Price | $26.85 | $116.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 20 |
| Target Price | N/A | ★ $130.90 |
| AVG Volume (30 Days) | 3.9M | ★ 5.9M |
| Earning Date | 04-28-2026 | 04-16-2026 |
| Dividend Yield | 1.94% | ★ 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $16.44 | $10.75 |
| Revenue Next Year | $4.27 | $8.10 |
| P/E Ratio | ★ $10.92 | $187.08 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $19.29 | $81.97 |
| 52 Week High | $28.69 | $137.49 |
| Indicator | BCS | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 43.92 | 77.69 |
| Support Level | $26.54 | $111.18 |
| Resistance Level | $28.50 | $116.82 |
| Average True Range (ATR) | 0.35 | 2.16 |
| MACD | -0.20 | 0.26 |
| Stochastic Oscillator | 16.70 | 98.15 |
Barclays is a universal bank headquartered in the United Kingdom. It operates via five principal segments; Barclays UK (retail), UK corporate bank, private bank and wealth management, investment bank, and US consumer bank. In its UK segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The US consumer bank includes a co-branded credit card and unsecured lending business. The investment bank offers global markets, financing, and advisory services.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.